L Chen, M Kostadima, JHA Martens, G Canu, SP Garcia, E Turro, K Downes, IC Macaulay, E Bielczyk-Maczynska, S Coe, S Farrow, P Poudel, F Burden, SBG Jansen, WJ Astle, A Attwood, T Bariana, B de Bono, A Breschi, JC Chambers, B Consortium, FA Choudry, L Clarke, P Coupland, M van der Ent, WN Erber, JH Jansen, R Favier, ME Fenech, N Foad, K Freson, C van Geet, K Gomez, R Guigo, D Hampshire, AM Kelly, HHD Kerstens, JS Kooner, M Laffan, C Lentaigne, C Labalette, T Martin, S Meacham, A Mumford, S Nürnberg, E Palumbo, BA van der Reijden, D Richardson, SJ Sammut, G Slodkowicz, AU Tamuri, L Vasquez, K Voss, S Watt, S Westbury, P Flicek, R Loos, N Goldman, P Bertone, RJ Read, S Richardson, A Cvejic, N Soranzo, WH Ouwehand, HG Stunnenberg, M Frontini, A Rendon
Blood cells derive from hematopoietic stem cells through stepwise fating events. To characterize gene expression programs driving lineage choice, we sequenced RNA from eight primary human hematopoietic progenitor populations representing the major myeloid commitment stages and the main lymphoid stage. We identified extensive cell type-specific expression changes: 6711 genes and 10,724 transcripts, enriched in non-protein-coding elements at early stages of differentiation. In addition, we found 7881 novel splice junctions and 2301 differentially used alternative splicing events, enriched in genes involved in regulatory processes. We demonstrated experimentally cell-specific isoform usage, identifying nuclear factor I/B (NFIB) as a regulator of megakaryocyte maturation-the platelet precursor. Our data highlight the complexity of fating events in closely related progenitor populations, the understanding of which is essential for the advancement of transplantation and regenerative medicine.